Yeshwant Krishna
- SEC CIK
- 0001585001
No open-market purchases or sales filed in the past year.
Current role at each company
- PBLS Parabilis Medicines, Inc.Directoras of Jun 11, 2026
- VERV Verve Therapeutics, Inc.Director, 10% Owneras of Jul 28, 2025
- EQRX EQRx, Inc.Directoras of Nov 9, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Yeshwant Krishna as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VERV Verve Therapeutics, Inc.
Director, 10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2023 (view filing) | Dec 1 | 4 days | Yeshwant KrishnaDirector, 10% Owner | PPurchase | +1.80M | $10.00 | +$18.0M | New position1.80M after | |
| Nov 8, 2022 (view filing) | Nov 4 | 4 days | Yeshwant KrishnaDirector, 10% Owner | SSale | −48.6K | $31.14 | −$1.51M | −1.1%4.26M after | 3 lots |
| Nov 4, 2022 (view filing) | Nov 2-3 | 2 days | Yeshwant KrishnaDirector, 10% Owner | SSale | −78.2K | $33.95 | −$2.66M | −1.8%4.31M after | 6 lots |
| Nov 2, 2022 (view filing) | Oct 31-Nov 1 | 2 days | Yeshwant KrishnaDirector, 10% Owner | SSale | −85.7K | $37.95 | −$3.25M | −1.9%4.39M after | 7 lots |